胃肠道疾病: 胃潰瘍疾病 胃潰瘍疾病
1Procedural Institute for Full Circle Health, Boise, Idaho.
FP essentials
|May 20, 2024
概括
胃潰瘍疾病 (PUD) 是由H. pylori和NSAIDs引起的. 新的诺普拉赞三重疗法在有效治疗PUD方面显示出前景.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 胃病 (PUD) 影响全球5-10%,以胃或十二指肠粘膜为特征.
- 主要原因包括Helicobacter pylori感染和非类固醇抗炎药物 (NSAID) 的使用.
- 由于改善了H. pylori的管理,保守的NSAID使用和质子抑制剂 (PPI) 的流行,PUD的发病率有所下降.
研究的目的:
- 审查胃病的流行病学,诊断和管理.
- 突出PUD治疗的进展,包括新疗法.
主要方法:
- 关于PUD流行病学,病因学和临床表现的文献综述.
- 分析诊断策略,包括内镜和非侵入性检测.
- 评估目前和新兴的PUD治疗方案.
主要成果:
- 常见的PUD症状如腹痛和恶心与其他疾病重叠,使诊断复杂化.
- 内镜是诊断的黄金标准,特别是在老年患者或有警报症状的患者中.
- 使用vonoprazan和抗生素的新三重疗法证明了其优越性,而不是传统的PPI治疗PUD.
结论:
- 对H. pylori和NSAIDs的有效管理降低了PUD的发生率.
- 准确的诊断依赖于临床怀疑,内镜或测试和治疗策略.
- 基于诺普拉赞的三重疗法代表了PUD治疗疗效的显著进步.
相关概念视频
Peptic Ulcer Disease I: Introduction
163
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
163
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
380
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
380
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
111
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
111
Peptic Ulcer Disease IV: Management
88
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
88
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
570
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
570
Peptic Ulcer Disease II: Pathophysiology
390
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
390


